Transfusion – Antenatal Serology —
Training activity: 5

Details

Provide advice on the appropriate use of anti-D in prevention of HDFN

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Considerations

• Differences between routine anti-D prophylaxis and prophylaxis for potentially sensitising events.
• Guidelines relating to anti-D prophylaxis

Reflective practice guidance

The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.

Before action

• What is your current understanding of Haemolytic Disease of the Fetus and Newborn (HDFN) and the role of anti-D in its prevention? What are the current guidelines regarding the administration of anti-D prophylaxis?
• What resources or guidelines will you consult to ensure your advice on anti-D is accurate and up-to-date? Will you discuss different clinical scenarios with your training officer to prepare for various situations requiring anti-D advice? What factors need to be considered when determining the appropriate use of anti-D?
• What specific scenarios or patient histories do you anticipate encountering where providing advice on anti-D will be critical? What potential challenges might arise when communicating this advice to healthcare professionals? How do you feel about the responsibility of providing this advice?

In action

• Pay attention to how you are formulating your advice on anti-D use. What information are you prioritising when giving this advice?
• What decisions are you making regarding the specific circumstances under which anti-D should be administered and the appropriate dosage?
• How effective are you in conveying the necessary information clearly and accurately? Are you confident that the advice you are giving is appropriate for the situation?
• What challenges are you facing in determining the appropriate use of anti-D, such as interpreting patient history or guidelines in specific scenarios?
• Are there alternative ways you could explain the rationale for anti-D administration or the dosage recommendations if the healthcare professional you are advising has questions or seems unsure?
• What support or further information might you need in the moment to ensure you are providing the most appropriate advice?
• Are you working within the scope of your training and referring to relevant guidelines?

On action

• What were the key pieces of information you considered when formulating your advice on anti-D use?
  • What was the specific scenario or context in which you provided this advice?
  • What questions or concerns were raised by the individual you were advising (if applicable)?
  • What was your initial approach to providing the advice?
  • How did your reflect-in-action (your considerations and adjustments while formulating the advice) influence the information you shared?
• Did you enhance your understanding of the specific guidelines for anti-D prophylaxis in different situations?
  • Did you learn anything new about the practical challenges in applying these guidelines?
  • Were there any unexpected aspects of the situation or the interaction that provided learning opportunities?
  • How did your reflection-in-action contribute to your understanding of the nuances of providing this advice?
  • How does this experience relate to the importance of preventing HDFN in post-programme practice?
• What areas related to providing advice on anti-D use have you identified for further development?#
  • How will you incorporate the learning from this experience into your future interactions and decision-making regarding anti-D prophylaxis?
  • What actions will you take to solidify your understanding of anti-D guidelines and their application?
  • What resources or support would be beneficial for your continued learning in this area?

Beyond action

• Have you had opportunities to re-evaluate the specific instances where you provided or considered advice on the appropriate use of anti-D for HDFN prevention since completing this training activity?
• Have you compared these experiences with other relevant activities, such as attending an anti-D clinic or a fetal medicine unit clinic, or discussions with healthcare professionals? How have your views evolved?
• Have you revisited your initial reflections (reflect-on-action) on this activity? What deeper understanding of the guidelines and considerations for anti-D use have you gained since then?
• How has this training activity contributed to your overall understanding of the importance of adhering to current guidelines regarding anti-D prophylaxis and its role in preventing Haemolytic Disease of the Fetus and Newborn (HDFN)?
• How has your experience in considering the appropriate use of anti-D influenced your communication skills when discussing preventative measures with healthcare professionals?
• Consider how this training activity has enhanced your awareness and appreciation of your specialty’s impact on patient care, particularly concerning the well-being of mothers and newborns.
• What transferable skills, such as applying guidelines, risk assessment, and communicating important health information, did you develop through this activity that will be valuable in various aspects of your future practice?
• Identify clear actions for continued development in your knowledge of anti-D prophylaxis and the prevention of HDFN. How will you ensure you remain up-to-date with evolving guidelines and best practices?

Relevant learning outcomes

#	Outcome
# 1	Outcome Practice in accordance with antenatal serology standards and guidelines.
# 3	Outcome Perform and interpret clinical and laboratory investigations to identify cases of haemolytic disease of the fetus or newborn (HDFN).
# 4	Outcome Identify sequential testing algorithms appropriate to the samples under investigation for HDFN.
# 5	Outcome Predict current and future pregnancies at highest risk of HDFN.
# 6	Outcome Identify and advise healthcare professionals on appropriate actions to manage HDFN.
# 7	Outcome Develop management plans including selection of blood components for mother, fetus and neonates during pregnancy.
# 8	Outcome Identify actions required in cases of potentially sensitising events during pregnancy.